The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

CTL/SAST/26-27/01090 11thAugust2026 BSE Limited KMC Speciality Hospitals (India) Limited Phiroze Jeejeebhoy Towers No. 6, Royal Road, Cantonment, Dalal Street, Trichy -620 001 Mumbai-400001 E-mail: cs.kmcshil@kauveryhospital.com Dear Sir/Madam, Sub: Disclosure pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in relation to pledge of and non-disposal undertaking in relation to Equity Shares of Sri Kauvery Medical Care (India) Limited Debenture Trustee (i) creation of pledge over 14.53% (fourteen point five three percent) of the shareholding of Sri SKMCIL certain promoter shareholders of SKMCIL, for the benefit of the debenture holders under the debenture trust deed dated July 6, 2026 executed between Prospera Healthcorp Issuer Debenture Trust Deed such shareholders Pledge Agreement (ii) creation of non-disposal undertaking over 32.40% (thirty two point four zero percent) of the shareholding of SKMCIL by certain promoter shareholders of SKMCIL, for the benefit of the debenture holders, under the Debenture Trust Deed, in accordance with the non-disposal undertaking provided by such shareholders Non-Disposal Undertakings SKMCIL holds 75% of shareholding in KMC Speciality Hospitals (India) Limited Target Company TC ). The enclosed disclosure is being made under Regulation 29(1) read with Regulation 29(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Takeover Regulations towards indirect encumbrance. Kindly take the same on record. For Catalyst Trusteeship Limited (Formerly known as GDA Trusteeship Limited) Authorised Signatory Name:Deesha Srikkanth Designation:Senior Vice President Place: Mumbai Date: 11thAugust2026 Encl: As above ANNEXURE Disclosures under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) KMC Speciality Hospitals (India) Limited Name(s) of the acquirer and Persons Acting in Catalyst Trusteeship Limited acting as Debenture Trustee on behalf Concert (PAC) with the acquirer Debenture Holder(s) of PROSPERA HEALTHCORP PRIVATE LIMITED(CIN -U70200TN2026PTC190163). Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock Exchange(s) where the BSE Limited shares of TC are Listed Details of the acquisition as follows Number % w.r.t. total % w.r.t. total share/voting diluted capital share/voting wherever capital of the applicable TC(**) Before the acquisition under consideration, holding of: a) Shares carrying voting rights NIL NIL NIL b) Shares in nature of encumbrance NIL NIL NIL (pledge/lien/non-disposal undertaking/others) c) Voting rights (VR) otherwise than by NIL NIL shares NIL d) Warrants/convertible securities/ any NIL NIL NIL other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) NIL NIL NIL Details of acquisition/sale: a) Shares carrying voting rights NIL NIL NIL acquired/sold b) VRs acquired/sold otherwise than by equityshares NIL NIL NIL c) Warrants/convertible securities/any other instrument that entitles the acquirer NIL NIL NIL to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked / released (i) Pledge over 74,10,831 Please see Note Please see Note by the acquirer equity shares of 1 below 1 below SKMCIL, aggregating to 14.53% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee; and (ii)Non-disposal undertaking over 1,65,32,316 equity shares of SKMCIL, aggregating to 32.40%of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee. Please refer to Note 1 below. Encumbrance over Please see Note Please see Note 2,39,43,147 equity shares of 1 below 1 below SKMCIL, aggregating to 46.93% of the fully diluted e) Total (a+b+c+/-d) shareholding of SKMCIL in favour of the Debenture Trustee. Please see Note 1 below. After the acquisition/sale, holding of: a) Shares carrying voting rights NIL NIL NIL b) Shares encumbered with the acquirer (i) Pledge over 74,10,831 Please see Note Please see Note equity shares of 1 below 1 below SKMCIL, aggregating to 14.53% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee; and (ii)Non-disposal undertaking over 1,65,32,316 equity shares of SKMCIL, aggregating to 32.40% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee. Please refer to Note 1 below. c) VRs otherwise than by shares NIL NIL NIL d) Warrants/convertible securities/any other instrument that entitles the acquirer NIL NIL NIL to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition Encumbrance over Please see Note Please see Note e) Total (a+b+c+d) 2,39,43,147 equity shares of 1 below 1 below SKMCIL, aggregating to 46.93% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee. Please see Note 1 below. Mode of acquisition / sale (e.g. open market / By way of indirect off-market /public issue / rights issue / encumbrance vide the preferential allotment / inter-se transfer etc.) following encumbrance being created over theequity shares of SKMCIL, which holds 75% of the shareholding of the Target Company: (i) pledge over 74,10,831 equity shares of SKMCIL, aggregating to 14.53% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee;and (ii)non-disposal undertaking over 1,65,32,316 equity shares of SKMCIL, aggregating to 32.40% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee. Please refer to Note 1 below. Date of acquisition / sale of shares / VR or date Please refer to Note 2 of receipt of intimation of allotment of shares, below. whichever is applicable Equity share capital / total voting capital of the INR 16,30,85,000 divided TC before the said acquisition/ sale into 16,30,85,000 equity shares of INR 1/-each Equity share capital / total voting capital of the INR 16,30,85,000 divided TC after the said acquisition/ sale into 16,30,85,000 equity shares of INR 1/-each (No change) Total diluted share / voting capital of the TC INR 16,30,85,000 divided after the said acquisition / sale. into 16,30,85,000 equity shares of INR 1/-each (No change) Note: (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Note 1: (a) SKMCIL holds 12,23,13,750 Shares in the Target Company, constituting 75% of the issued and paid-up share capital ofthe Target Company. (b) Issuer has issued certain non-convertible debentures under Debentures (c) The following encumbrance has been created by certain promoter shareholders of SKMCIL on the shareholding of SKMCIL pursuant to the Pledge Agreement and the Non-Disposal Undertakings respectively, to secure the Debentures: (i) pledge over 74,10,831 equity shares of SKMCIL, aggregating to 14.53% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee; and (ii) non-disposal undertaking over 1,65,32,316 equity shares of SKMCIL, aggregating to 32.40% of the fully diluted shareholding of SKMCIL in favour of the Debenture Trustee. (d) It is hereby clarified that the indirect encumbrance arises solely by virtue of a pledge/non-disposal undertakingover the shares of SKMCIL, the holding companyof the Target Company, and not by way of any direct pledge or other encumbrance over the shares of the Target Company Note 2: (a) The Pledge Agreement was executed on July 07, 2026. In terms of the Pledge Agreement, the pledge was required to be created over 74,10,831 equity shares of SKMCIL, aggregating to 14.53% of the fully diluted shareholding of SKMCIL in favour of the DebentureTrustee. (b) The Non-Disposal Undertaking was executed on July 06, 2026. In terms of the Non-Disposal Under [Showing first 8,000 characters — download PDF for full document]